Overview
Jan Bogeholz practices in Zurich, Switzerland. Bogeholz is rated as a Distinguished expert by MediFind in the treatment of Rubella. Their top areas of expertise are Rubella, Mumps, Togaviridae Disease, and Measles.
Their clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Rubella.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MumpsBogeholz isDistinguished. Learn about Mumps.
- RubellaBogeholz isDistinguished. Learn about Rubella.
- Advanced
- MeaslesBogeholz isAdvanced. Learn about Measles.
- ParainfluenzaBogeholz isAdvanced. Learn about Parainfluenza.
- Togaviridae DiseaseBogeholz isAdvanced. Learn about Togaviridae Disease.
- Experienced
- AgranulocytosisBogeholz isExperienced. Learn about Agranulocytosis.
- Hodgkin LymphomaBogeholz isExperienced. Learn about Hodgkin Lymphoma.